Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enoxaparin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03664180
What this trial is testing

Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI

Who this might be right for
STEMI - ST Elevation Myocardial Infarction
Beijing Anzhen Hospital 2,989
Not applicableStudy completedNCT01068795
What this trial is testing

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Who this might be right for
Fetal DemiseFetal Growth RestrictionPreeclampsia+2 more
HaEmek Medical Center, Israel 144
Not applicableStudy completedNCT02795065
What this trial is testing

Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients

Who this might be right for
Venous Thromboembolism
Mohamed Sayed Mohamed Abbas 100
Testing effectiveness (Phase 2)UnknownNCT03254511
What this trial is testing

Addition of Enoxaparin to Neoadjuvant Chemoradiation of Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Mashhad University of Medical Sciences 100
Large-scale testing (Phase 3)Study completedNCT00785421
What this trial is testing

Chemotherapy With or Without Enoxaparin in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CONKO-Studiengruppe 312
Post-approval studies (Phase 4)Study completedNCT00351663
What this trial is testing

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients

Who this might be right for
Venous ThrombosisCritical Illness
Shaare Zedek Medical Center 39
Large-scale testing (Phase 3)Study completedNCT02072434
What this trial is testing

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 2,199
Large-scale testing (Phase 3)Ended earlyNCT04400799
What this trial is testing

Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19

Who this might be right for
COVID-19Pulmonary Embolism, Deep Vein Thrombosis
University of Zurich 475
Not applicableStudy completedNCT01133002
What this trial is testing

Canadian Outpatient VTE Management Registry

Who this might be right for
Medical Prevention Therapy
Sanofi 915
Large-scale testing (Phase 3)Study completedNCT04646655
What this trial is testing

Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19

Who this might be right for
Covid19Thrombosis
ASST Fatebenefratelli Sacco 142
Post-approval studies (Phase 4)Study completedNCT02444572
What this trial is testing

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®

Who this might be right for
Gastrointestinal NeoplasmsThromboembolic Event
Les Laboratoires des Médicaments Stériles 168
Not applicableActive Not RecruitingNCT07787377
What this trial is testing

Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative Vitreoretinopathy

Who this might be right for
Rhegmatogenous Retinal Detachment With Grade C Proliferative Vitreoretinopathy
Lahore General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00074828
What this trial is testing

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Who this might be right for
Total Knee ReplacementTotal Hip Replacement
Eli Lilly and Company 511
Testing effectiveness (Phase 2)Ended earlyNCT02589145
What this trial is testing

Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT03891524
What this trial is testing

JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
Arthroplasty, Replacement, Knee
Janssen Research & Development, LLC 1,242
Not applicableUnknownNCT02085824
What this trial is testing

Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.

Who this might be right for
Hip OsteoarthritisBlood Loss
Centre of Postgraduate Medical Education 60
Large-scale testing (Phase 3)Study completedNCT00093158
What this trial is testing

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

Who this might be right for
Unstable AnginaMyocardial InfarctionAcute Disease
The Medicines Company 13,800
Large-scale testing (Phase 3)Study completedNCT00571649
What this trial is testing

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

Who this might be right for
Venous Thromboembolism
Bayer 8,101
Large-scale testing (Phase 3)Study completedNCT00077844
What this trial is testing

Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)

Who this might be right for
Percutaneous Coronary Intervention
Sanofi 3,532
Large-scale testing (Phase 3)Study completedNCT01205932
What this trial is testing

Dose-confirmatory Bridging Study in Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 402
Next Page